We are live on
!
Find out more
OAG
Oakmont Advisory Group Portfolio holdings
AUM
$119M
This Fund
S&P 500
This Quarter
Est. Return
-0.82%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$98.2M
AUM Growth
+$4.5M
(+4.8%)
Cap. Flow
+$5.89M
Cap. Flow
% of AUM
6%
Top 10 Holdings %
Top 10 Hldgs %
43.09%
Holding
130
New
14
Increased
61
Reduced
44
Closed
11
Avg Time Held
0.9
quarters
Top 10 Avg Time Held
0.9
quarters
Top 20 Avg Time Held
0.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DFUS
Dimensional US Equity ETF
DFUS
|
+$1.97M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.94M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$1.01M |
| 4 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$910K |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$879K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.2M |
| 2 |
Invesco S&P 500 Low Volatility ETF
SPLV
|
+$854K |
| 3 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$831K |
| 4 |
FT Vest US Equity Buffer ETF September
FSEP
|
+$823K |
| 5 |
FT Vest US Equity Buffer ETF October
FOCT
|
+$822K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 80.61% |
| 2 | Healthcare | 4.84% |
| 3 | Technology | 4.13% |
| 4 | Consumer Staples | 3.24% |
| 5 | Consumer Discretionary | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Merck
MRK
$356B
| $342K | 0.35% |
2,847
-433
| -13% | -$50K |
2025 Q4
1 quarter
|
|
77
Chewy
CHWY
$7.3B
| $339K | 0.34% |
12,538
+3,302
| +36% | +$92K |
2025 Q4
1 quarter
|
|
78
Exelixis
EXEL
$14.5B
| $336K | 0.34% |
7,831
+506
| +7% | +$21.8K |
2025 Q4
1 quarter
|
|
79
iShares Emerging Markets Dividend ETF
DVYE
$1.19B
| $335K | 0.34% |
9,737
+213
| +2% | +$7.2K |
2025 Q4
1 quarter
|
|
80
Toast
TOST
$17.2B
| $330K | 0.34% |
+12,461
| New | +$372K |
2026 Q1
0 quarters
|
|
81
Altria Group
MO
$112B
| $330K | 0.34% |
5,005
-702
| -12% | -$45.2K |
2025 Q4
1 quarter
|
|
82
Merit Medical Systems
MMSI
$5.1B
| $329K | 0.34% |
4,775
+800
| +20% | +$62.5K |
2025 Q4
1 quarter
|
|
83
Gilead Sciences
GILD
$179B
| $328K | 0.33% |
2,351
-380
| -14% | -$53.2K |
2025 Q4
1 quarter
|
|
84
CME Group
CME
$94.6B
| $327K | 0.33% |
1,107
-118
| -10% | -$35K |
2025 Q4
1 quarter
|
|
85
Ralph Lauren
RL
$21.7B
| $327K | 0.33% |
950
+68
| +8% | +$24.2K |
2025 Q4
1 quarter
|
|
86
Cboe Global Markets
CBOE
$28.3B
| $327K | 0.33% |
1,162
-158
| -12% | -$44K |
2025 Q4
1 quarter
|
|
87
Snap-on
SNA
$19.1B
| $324K | 0.33% |
893
-87
| -9% | -$32.2K |
2025 Q4
1 quarter
|
|
88
Insulet
PODD
$9.13B
| $320K | 0.33% |
1,525
+395
| +35% | +$99.3K |
2025 Q4
1 quarter
|
|
89
Elanco Animal Health
ELAN
$11.1B
| $318K | 0.32% |
13,304
-670
| -5% | -$16.4K |
2025 Q4
1 quarter
|
|
90
T. Rowe Price
TROW
$22.3B
| $317K | 0.32% |
3,517
+402
| +13% | +$38.9K |
2025 Q4
1 quarter
|
|
91
Halozyme
HALO
$12.5B
| $317K | 0.32% |
+4,899
| New | +$345K |
2026 Q1
0 quarters
|
|
92
Procter & Gamble
PG
$337B
| $316K | 0.32% |
2,186
-115
| -5% | -$17.4K |
2025 Q4
1 quarter
|
|
93
Tesla
TSLA
$1.46T
| $313K | 0.32% |
841
+4
| +0.5% | +$1.65K |
2025 Q4
1 quarter
|
|
94
Vanguard International Dividend Appreciation ETF
VIGI
$8.84B
| $310K | 0.32% |
3,499
+117
| +3% | +$10.8K |
2025 Q4
1 quarter
|
|
95
Illinois Tool Works
ITW
$74.9B
| $309K | 0.32% |
1,188
-166
| -12% | -$45.2K |
2025 Q4
1 quarter
|
|
96
PepsiCo
PEP
$172B
| $306K | 0.31% |
1,968
-182
| -8% | -$28.4K |
2025 Q4
1 quarter
|
|
97
Abbott
ABT
$169B
| $304K | 0.31% |
2,965
+464
| +19% | +$52.4K |
2025 Q4
1 quarter
|
|
98
VICI Properties
VICI
$24.9B
| $303K | 0.31% |
11,106
-306
| -3% | -$8.76K |
2025 Q4
1 quarter
|
|
99
Comcast
CMCSA
$76.5B
| $303K | 0.31% |
10,566
-991
| -9% | -$29.7K |
2025 Q4
1 quarter
|
|
100
Eli Lilly
LLY
$1.02T
| $303K | 0.31% |
+329
| New | +$334K |
2026 Q1
0 quarters
|
|
Similar funds
BCM
FA
DFC
VIP
RMF
AA
AW
BAM
Oakmont Advisory Group's Q1 2026 Portfolio in Review
As of Q1 2026, Oakmont Advisory Group held 130 positions worth $98.2M, up 4.8% from $93.7M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Oakmont Advisory Group deployed $5.89M of net new capital in Q1 2026, opening 14 new positions and adding to 61 existing holdings. Its largest new stake was State Street Health Care Select Sector SPDR ETF: 5,700 shares worth $836K.
By sector, the portfolio is most concentrated in Miscellaneous at 81% of assets, up from 80% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Invesco S&P 500 Equal Weight ETF, an estimated $2.2M trimmed.
- Oakmont Advisory Group's largest Q1 2026 buy was State Street Health Care Select Sector SPDR ETF: 5,700 shares worth $836K.
- Oakmont Advisory Group added most to Dimensional US Equity ETF in Q1 2026, an estimated $1.97M increase.
- Oakmont Advisory Group's biggest Q1 2026 reduction was Invesco S&P 500 Equal Weight ETF, cutting an estimated $2.2M.
- Oakmont Advisory Group fully exited FT Vest US Equity Buffer ETF September in Q1 2026, selling an estimated $823K.
- Oakmont Advisory Group's ten largest holdings make up 43% of its $98.2M portfolio in Q1 2026.
- Oakmont Advisory Group opened 14 new positions and closed 11 in Q1 2026.
- Oakmont Advisory Group's portfolio value rose 4.8% quarter-over-quarter to $98.2M.
Based on Oakmont Advisory Group's 13F filing for Q1 2026, filed 12 May 2026.